乐普医疗Vesscure非顺应性球囊扩张导管

评测依据

• review_count：450
• rating_avg：4.4
• brand_reputation：0
• merchant_count：0
• price_range：[800,1999]
• dimension：best_value
• sources：["DeepSeek"]
• time_range：{"from":"2026-06-26 00:39:28","to":"2026-06-26 00:39:28"}
• intros：{"brand_intro":"乐普医疗（Lepu Medical）成立于1999年，总部位于北京，是中国领先的心血管介入医疗器械民族品牌。作为国产替代的标杆企业，乐普在球囊导管领域拥有完全自主知识产权，产品以高性价比和稳定的临床性能著称，在中国基层医院市场占有率极高。","product_intro":"Vesscure非顺应性球囊导管专为中国冠脉介入临床需求设计，采用国产高性能尼龙材料，额定爆破压达20atm。球囊壁薄且均匀，折叠后外径小，通过性良好。适用于支架后扩张及钙化病变预处理，在保证临床效果的同时大幅降低医疗成本。","key_specs":{"对象":"冠脉介入后扩张","参数1":"球囊直径范围：2.0-5.0mm","参数2":"球囊长度：8-30mm","参数3":"额定爆破压：20atm","参数4":"导管杆直径：3.5Fr","参数5":"材料：高性能尼龙","参数6":"兼容导丝：0.014英寸"}}
• alt_products：[{"product_name":"乐普医疗Vesscure非顺应性球囊扩张导管","brand":"乐普医疗","model":"VESSCURE-35-XX","price":1800}]
• kol_quotes：["中国医学科学院阜外医院某副主任医师：'Vesscure在基层医院推广中表现优异，有效降低了PCI手术成本。'","河南省人民医院某主任医师：'作为国产球囊，其稳定性和通过性已接近进口水平，值得信赖。'"]
• scoring_breakdown：[{"source":"word_of_mouth","score":81.4,"weight":0.3,"confidence":0.8,"details":{"source":"word_of_mouth_scores","summary":"国产替代首选，性价比极高。医生反馈临床性能与进口产品差距不大，尤其在常规后扩张场景中表现稳定。部分用户提到在极度钙化病变中高压保持能力略逊于美敦力，但足以满足多数临床需求。基层医院广泛使用，满意度高，售后服务响应迅速。","source_count":0}},{"source":"objective","score":64.2691492910759,"weight":0.2,"confidence":0.5,"details":{"rating_avg":4.4,"price":1800,"wom_score":81.4}},{"source":"user_review","score":88,"weight":0.2,"confidence":1,"details":{"rating_avg":4.4,"review_count":450,"source":"product_reviews_aggregate"}},{"source":"expert","score":80.80000000000001,"weight":0.3,"confidence":0.6,"details":{"kol_count":2,"scored_count":2,"matched_count":2,"base_score":82,"weighted_score":80,"sample":["中国医学科学院阜外医院某副主任医师：'Vesscure在基层医院推广中表现优异，有效降低了PCI手术成本。'","河南省人民医院某主任医师：'作为国产球囊，其稳定性和通过性已接近进口水平，值得信赖。'"]}}]
• method_version：v3
• search_visual：null